{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.ai-analytics.org/api/v1/entity/PCVX/timeline","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://api.ai-analytics.org/license","usage_info":"https://api.ai-analytics.org/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-09-22T18:18:49.116Z","methodology_url":"https://api.ai-analytics.org/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":8998,"canonical_name":"Vaxcyte, Inc.","cik":"0001649094","uei":null,"lei":null,"duns":null,"ticker":"PCVX"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","open.payments","dol.form5500","hud.housing","irs.bmf"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":68,"clinical":4},"count":72,"timeline":[{"ts":"2026-09-02","kind":"sec.insider.3427","reporter":"PICKERING GRANT","title":"CHIEF EXECUTIVE OFFICER","shares":3427,"price_per_share":61.58,"usd_value":211035,"security_title":"Common Stock","importance":15.21103466},{"ts":"2026-09-02","kind":"sec.insider.1432","reporter":"Wassil Jim","title":"CHIEF OPERATING OFFICER","shares":1432,"price_per_share":61.58,"usd_value":88183,"security_title":"Common Stock","importance":15.08818256},{"ts":"2026-09-02","kind":"sec.insider.1432","reporter":"GUGGENHIME ANDREW","title":"PRESIDENT AND CFO","shares":1432,"price_per_share":61.58,"usd_value":88183,"security_title":"Common Stock","importance":15.08818256},{"ts":"2026-09-02","kind":"sec.insider.659","reporter":"Dhaliwal Harpreet S.","title":"Chief Technical Ops Officer","shares":659,"price_per_share":61.58,"usd_value":40581,"security_title":"Common Stock","importance":15.04058122},{"ts":"2026-09-02","kind":"sec.insider.326","reporter":"Cowan Elvia","title":"SVP, Finance & CAO","shares":326,"price_per_share":61.58,"usd_value":20075,"security_title":"Common Stock","importance":15.02007508},{"ts":"2026-09-01","kind":"sec.insider.1537","reporter":"Wassil Jim","title":"CHIEF OPERATING OFFICER","shares":1537,"price_per_share":60.886,"usd_value":93582,"security_title":"Common Stock","importance":15.093581782},{"ts":"2026-09-01","kind":"sec.insider.924","reporter":"Wassil Jim","title":"CHIEF OPERATING OFFICER","shares":924,"price_per_share":60.955,"usd_value":56322,"security_title":"Common Stock","importance":15.05632242},{"ts":"2026-09-01","kind":"sec.insider.713","reporter":"Wassil Jim","title":"CHIEF OPERATING OFFICER","shares":713,"price_per_share":61.481,"usd_value":43836,"security_title":"Common Stock","importance":15.043835953},{"ts":"2026-09-01","kind":"sec.insider.303","reporter":"Wassil Jim","title":"CHIEF OPERATING OFFICER","shares":303,"price_per_share":61.424,"usd_value":18611,"security_title":"Common Stock","importance":15.018611472},{"ts":"2026-09-01","kind":"sec.insider.2250","reporter":"Wassil Jim","title":"CHIEF OPERATING OFFICER","shares":2250,"price_per_share":5.35,"usd_value":12038,"security_title":"Common Stock","importance":15.0120375},{"ts":"2026-08-31","kind":"sec.insider.2862","reporter":"PICKERING GRANT","title":"CHIEF EXECUTIVE OFFICER","shares":2862,"price_per_share":60.74,"usd_value":173838,"security_title":"Common Stock","importance":15.17383788},{"ts":"2026-08-31","kind":"sec.insider.1273","reporter":"Wassil Jim","title":"CHIEF OPERATING OFFICER","shares":1273,"price_per_share":60.74,"usd_value":77322,"security_title":"Common Stock","importance":15.07732202},{"ts":"2026-08-31","kind":"sec.insider.1273","reporter":"GUGGENHIME ANDREW","title":"PRESIDENT AND CFO","shares":1273,"price_per_share":60.74,"usd_value":77322,"security_title":"Common Stock","importance":15.07732202},{"ts":"2026-08-31","kind":"sec.insider.361","reporter":"Dhaliwal Harpreet S.","title":"Chief Technical Ops Officer","shares":361,"price_per_share":60.74,"usd_value":21927,"security_title":"Common Stock","importance":15.02192714},{"ts":"2026-08-31","kind":"sec.insider.243","reporter":"Cowan Elvia","title":"SVP, Finance & CAO","shares":243,"price_per_share":60.74,"usd_value":14760,"security_title":"Common Stock","importance":15.01475982},{"ts":"2026-07-16","kind":"sec.filing","form_type":"3","title":"3 — Vaxcyte, Inc. — 2026-07-16","url_slug":"/sec/cik-0001649094/3/0001803424-26-000003","accession_number":"0001803424-26-000003","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"4","title":"4 — Vaxcyte, Inc. — 2026-07-16","url_slug":"/sec/cik-0001649094/4/0001803424-26-000004","accession_number":"0001803424-26-000004","importance":30},{"ts":"2026-07-15","kind":"sec.filing","form_type":"8-K","title":"8-K — Vaxcyte, Inc. — 2026-07-15","url_slug":"/sec/cik-0001649094/8-k/0001649094-26-000030","accession_number":"0001649094-26-000030","importance":35},{"ts":"2026-07-06","kind":"sec.form144","reporter":"GUGGENHIME ANDREW","title":"Officer","shares":10000,"usd_value":577600,"security_title":"Common","approx_sale_date":"2026-07-06","accession_number":"0001969223-26-000761","importance":40.11552},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"GUGGENHIME ANDREW","title":"PRESIDENT AND CFO","shares":7913,"price_per_share":57.157,"usd_value":452283,"security_title":"Common Stock","importance":35.452283341},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"GUGGENHIME ANDREW","title":"PRESIDENT AND CFO","shares":2087,"price_per_share":57.764,"usd_value":120553,"security_title":"Common Stock","importance":35.120553468},{"ts":"2026-07-06","kind":"sec.filing","form_type":"4","title":"4 — Vaxcyte, Inc. — 2026-07-06","url_slug":"/sec/cik-0001649094/4/0001813798-26-000013","accession_number":"0001813798-26-000013","importance":30},{"ts":"2026-07-06","kind":"sec.insider.m","reporter":"GUGGENHIME ANDREW","title":"PRESIDENT AND CFO","shares":10000,"price_per_share":5.35,"usd_value":53500,"security_title":"Common Stock","importance":15.0535},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Wassil Jim","title":"CHIEF OPERATING OFFICER","shares":1788,"price_per_share":56.03,"usd_value":100182,"security_title":"Common Stock","importance":35.10018164},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Wassil Jim","title":"CHIEF OPERATING OFFICER","shares":456,"price_per_share":57.473,"usd_value":26208,"security_title":"Common Stock","importance":35.026207688},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Wassil Jim","title":"CHIEF OPERATING OFFICER","shares":6,"price_per_share":57.82,"usd_value":347,"security_title":"Common Stock","importance":35.00034692},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"Wassil Jim","title":"CHIEF OPERATING OFFICER","shares":516,"price_per_share":5.35,"usd_value":2761,"security_title":"Common Stock","importance":15.0027606},{"ts":"2026-06-26","kind":"sec.form144","reporter":"PICKERING GRANT","title":"Officer, Director","shares":24237,"usd_value":1303223,"security_title":"Common","approx_sale_date":"2026-06-26","accession_number":"0001969223-26-000725","importance":40.260644698},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"PICKERING GRANT","title":"CHIEF EXECUTIVE OFFICER","shares":9137,"price_per_share":55.265,"usd_value":504956,"security_title":"Common Stock","importance":35.504956305},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"PICKERING GRANT","title":"CHIEF EXECUTIVE OFFICER","shares":6683,"price_per_share":54.275,"usd_value":362720,"security_title":"Common Stock","importance":35.362719825},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"PICKERING GRANT","title":"CHIEF EXECUTIVE OFFICER","shares":6417,"price_per_share":56.121,"usd_value":360128,"security_title":"Common Stock","importance":35.360128457},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"PICKERING GRANT","title":"CHIEF EXECUTIVE OFFICER","shares":602,"price_per_share":55.297,"usd_value":33289,"security_title":"Common Stock","importance":35.033288794},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"PICKERING GRANT","title":"CHIEF EXECUTIVE OFFICER","shares":356,"price_per_share":55.226,"usd_value":19660,"security_title":"Common Stock","importance":35.019660456},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"PICKERING GRANT","title":"CHIEF EXECUTIVE OFFICER","shares":332,"price_per_share":55.993,"usd_value":18590,"security_title":"Common Stock","importance":35.018589676},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"PICKERING GRANT","title":"CHIEF EXECUTIVE OFFICER","shares":312,"price_per_share":54.345,"usd_value":16956,"security_title":"Common Stock","importance":35.01695564},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"PICKERING GRANT","title":"CHIEF EXECUTIVE OFFICER","shares":207,"price_per_share":54.222,"usd_value":11224,"security_title":"Common Stock","importance":35.011223954},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"PICKERING GRANT","title":"CHIEF EXECUTIVE OFFICER","shares":191,"price_per_share":56.266,"usd_value":10747,"security_title":"Common Stock","importance":35.010746806},{"ts":"2026-06-23","kind":"sec.filing","form_type":"8-K","title":"8-K — Vaxcyte, Inc. — 2026-06-23","url_slug":"/sec/cik-0001649094/8-k/0001649094-26-000026","accession_number":"0001649094-26-000026","importance":35},{"ts":"2026-06-23","kind":"sec.filing","form_type":"3","title":"3 — Vaxcyte, Inc. — 2026-06-23","url_slug":"/sec/cik-0001649094/3/0001712369-26-000006","accession_number":"0001712369-26-000006","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"4","title":"4 — Vaxcyte, Inc. — 2026-06-23","url_slug":"/sec/cik-0001649094/4/0001712369-26-000008","accession_number":"0001712369-26-000008","importance":30},{"ts":"2026-06-18","kind":"sec.form144","reporter":"PICKERING GRANT","title":"Officer","shares":24461,"usd_value":1284205,"security_title":"Common","approx_sale_date":"2026-06-18","accession_number":"0001969223-26-000715","importance":40.25684095},{"ts":"2026-06-18","kind":"sec.form144","reporter":"GUGGENHIME ANDREW","title":"Officer","shares":10000,"usd_value":530000,"security_title":"Common","approx_sale_date":"2026-06-18","accession_number":"0001969223-26-000716","importance":40.106},{"ts":"2026-06-18","kind":"sec.insider.s","reporter":"PICKERING GRANT","title":"CHIEF EXECUTIVE OFFICER","shares":22236,"price_per_share":52.5,"usd_value":1167390,"security_title":"Common Stock","importance":36.16739},{"ts":"2026-06-18","kind":"sec.insider.s","reporter":"GUGGENHIME ANDREW","title":"PRESIDENT AND CFO","shares":10000,"price_per_share":53,"usd_value":530000,"security_title":"Common Stock","importance":35.53},{"ts":"2026-06-18","kind":"sec.insider.s","reporter":"PICKERING GRANT","title":"CHIEF EXECUTIVE OFFICER","shares":1000,"price_per_share":52.5,"usd_value":52500,"security_title":"Common Stock","importance":35.0525},{"ts":"2026-06-18","kind":"sec.insider.s","reporter":"PICKERING GRANT","title":"CHIEF EXECUTIVE OFFICER","shares":1000,"price_per_share":52.5,"usd_value":52500,"security_title":"Common Stock","importance":35.0525},{"ts":"2026-06-18","kind":"sec.insider.s","reporter":"PICKERING GRANT","title":"CHIEF EXECUTIVE OFFICER","shares":225,"price_per_share":52.51,"usd_value":11815,"security_title":"Common Stock","importance":35.01181475},{"ts":"2026-06-18","kind":"sec.insider.m","reporter":"GUGGENHIME ANDREW","title":"PRESIDENT AND CFO","shares":10000,"price_per_share":5.35,"usd_value":53500,"security_title":"Common Stock","importance":15.0535},{"ts":"2026-06-18","kind":"sec.insider.m","reporter":"PICKERING GRANT","title":"CHIEF EXECUTIVE OFFICER","shares":225,"price_per_share":1.79,"usd_value":403,"security_title":"Common Stock","importance":15.00040275},{"ts":"2026-06-16","kind":"sec.filing","form_type":"8-K","title":"8-K — Vaxcyte, Inc. — 2026-06-16","url_slug":"/sec/cik-0001649094/8-k/0001649094-26-000021","accession_number":"0001649094-26-000021","importance":35},{"ts":"2026-06-16","kind":"sec.filing","form_type":"4","title":"4 — Lukatch Heath — 2026-06-16","url_slug":"/sec/cik-0001596385/4/0001596385-26-000002","accession_number":"0001596385-26-000002","importance":30},{"ts":"2026-06-16","kind":"sec.filing","form_type":"4","title":"4 — Gilbert Halley E — 2026-06-16","url_slug":"/sec/cik-0001601360/4/0001601360-26-000002","accession_number":"0001601360-26-000002","importance":30},{"ts":"2026-06-16","kind":"sec.filing","form_type":"4","title":"4 — Vaxcyte, Inc. — 2026-06-16","url_slug":"/sec/cik-0001649094/4/0001691218-26-000002","accession_number":"0001691218-26-000002","importance":30},{"ts":"2026-06-16","kind":"sec.filing","form_type":"4","title":"4 — Vaxcyte, Inc. — 2026-06-16","url_slug":"/sec/cik-0001649094/4/0001829111-26-000009","accession_number":"0001829111-26-000009","importance":30},{"ts":"2026-06-16","kind":"sec.filing","form_type":"4","title":"4 — Vaxcyte, Inc. — 2026-06-16","url_slug":"/sec/cik-0001649094/4/0001935943-26-000002","accession_number":"0001935943-26-000002","importance":30},{"ts":"2026-06-15","kind":"sec.insider.a","reporter":"Drapeau Anne S","title":null,"shares":2265,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-15","kind":"sec.insider.a","reporter":"BRANDICOURT OLIVIER","title":null,"shares":2194,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-15","kind":"sec.insider.a","reporter":"Lukatch Heath","title":"","shares":2265,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-15","kind":"sec.insider.a","reporter":"Gilbert Halley E","title":null,"shares":2265,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-15","kind":"sec.insider.a","reporter":"Paya Carlos V","title":null,"shares":2265,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-15","kind":"sec.insider.a","reporter":"Furey John","title":null,"shares":2265,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-15","kind":"sec.insider.a","reporter":"Loxam Teri","title":null,"shares":2265,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-15","kind":"sec.insider.a","reporter":"Lee Jacks","title":null,"shares":2265,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-03","kind":"sec.filing","form_type":"4","title":"4 — Vaxcyte, Inc. — 2026-06-03","url_slug":"/sec/cik-0001649094/4/0001813798-26-000011","accession_number":"0001813798-26-000011","importance":30},{"ts":"2026-06-01","kind":"sec.form144","reporter":"Wassil Jim","title":"Officer","shares":2250,"usd_value":114773,"security_title":"Common","approx_sale_date":"2026-06-01","accession_number":"0001969223-26-000620","importance":40.0229545},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Wassil Jim","title":"CHIEF OPERATING OFFICER","shares":1949,"price_per_share":49.404,"usd_value":96288,"security_title":"Common Stock","importance":35.096288396},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Wassil Jim","title":"CHIEF OPERATING OFFICER","shares":301,"price_per_share":50.257,"usd_value":15127,"security_title":"Common Stock","importance":35.015127357},{"ts":"2026-06-01","kind":"sec.filing","form_type":"144","title":"144 — Vaxcyte, Inc. — 2026-06-01","url_slug":"/sec/cik-0001649094/144/0001969223-26-000620","accession_number":"0001969223-26-000620","importance":30},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Vaxcyte, Inc.","title":"Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49","security_title":"PHASE3","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT07284654","excerpt":"[\"Pneumococcal Vaccines\"]","importance":60},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Vaxcyte, Inc.","title":"A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age","security_title":"PHASE3","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT07365826","excerpt":"[\"Pneumococcal Vaccines\"]","importance":60},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Vaxcyte, Inc.","title":"A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants","security_title":"PHASE2","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT06720038","excerpt":"[\"Pneumococcal Vaccines\"]","importance":45},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Vaxcyte, Inc.","title":"Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal Vaccination","security_title":"PHASE3","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT07425392","excerpt":"[\"Pneumococcal Vaccines\"]","importance":60}]}